海角视频

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Tech

Major investment to help Hull healthtech innovator turn up the volume on 'pharmaceutical' soothing sounds

MediMusic ready to turn up the volume after funding success in public and private sector

Dr Jacqueline Twamley, academic research and innovation manager at the Centre for Health Research & Innovation at Lancashire Teaching Hospitals NHS Foundation Trust, administering MediMusic to nurse Sheleen Armstrong at Chorley and South Ribble Hospital on new trial involving 40 NHS staff working in critical care to help combat work stress.(Image: MediMusic / Larkin PR)

A medical technology start-up that uses soothing music to help patients combat pain and anxiety is to scale up after securing investment worth £1.2 million.

MediMusic launched in Hull last year, attracting national interest when its artificial intelligence-compiled playlists were proven to ease stress for dementia patients in NHS trials. It works via an app and streaming service, with the technology targeted at hospitals, dental surgeries and care homes to help manage chronic pain or support patients before and after operations.

A £200,000 seedcorn investment from Finance Yorkshire is supported by investment from University of Hull and fellow C4DI business Sauce Consultants Ltd, with the balance coming from private investors.

Read more: Future of tech highlighted in Hull as Apple and KCom share stage

MediMusic chief executive and co-founder Gary Jones is an entrepreneur with 30 years’ experience in content management and music. He has spent seven years developing the business and the streaming platform.

He said: “This investment will take MediMusic to the next level. We passionately believe this will be a real game-changer in how we treat dementia patients and people suffering from pain, anxiety and stress.

MediMusic chief executive and co-founder Gary Jones, centre, with Alex McWhirter, chief executive of Finance Yorkshire, left and Ian Brown, head of investment at Anticus Partners, manager of the Finance Yorkshire Equity Fund.(Image: Finance Yorkshire)

“MediMusic has managed to digitally fingerprint the DNA of music so we can deliver the right songs as medicine. You could say it’s a musical pharmaceutical. Our initial clinical trials prove it has a very encouraging future in the treatment of patients.”

As reported, work with Lancashire Teaching Hospitals NHS Foundation Trust found the use of MediMusic led to a reduction in heart rate of up to 22 per cent in patients with dementia during the Covid-19 pandemic.